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Abstract
Human B lymphocytes express an ATP-gated ion channel (P2Z receptor), which shares similarities with the recently
identified P2X7 receptor. Using gene specific primers, we have now isolated P2X7 cDNA from the total RNA of human B
lymphocytes. This hP2X7 receptor subtype was expressed in Xenopus oocytes and electrophysiologically characterized. The
hP2X7 receptor is similar to, but does not completely match, P2Z of human B cells. The hP2X7 receptors resemble the P2Z
receptors with regard to the ATP concentration of half maximal activation, reproducibility, permeation characteristics and
lack of desensitization of the ATP-evoked currents. However, in contrast to the native lymphocytic P2Z receptor, the time
course of activation of hP2X7 displayed an additional linearly increasing current component. Furthermore, a second, small
and slowly deactivating current component exists only in hP2X7 expressed in oocytes. The activation and deactivation
kinetics as well as permeation characteristics of hP2X7 are different from rat P2X7 recently expressed in oocytes. Unlike in
mammalian cells, hP2X7 expressed in Xenopus oocytes is not sufficient to induce large non-selective pores. ß 2000 Elsevier
Science B.V. All rights reserved.
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1. Introduction
Cells of the immune and in£ammatory system ex-
press a distinct subtype of receptors for extracellular
ATP (P2X receptors), named P2Z. Like the other
subtypes of the P2X receptor family, the P2Z recep-
tor is regarded as a ligand-gated ion channel. It is
opened by free uncomplexed ATP43 in the 100 WM
range. 3P-O-(4-Benzoyl)benzoyl-ATP (BzATP) which
opens P2Z channels at about one tenth of the ATP
concentrations needed to activate P2Z is considered
to be the typical and selective agonist. Oxidized ATP
(oATP) acts as an irreversible antagonist on P2Z [1].
In macrophages, ¢broblasts and mast cells, ATP in-
duces large pores in the cell membrane which allow
the permeation of molecules as large as 900 Da [1].
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The precise in vivo function of P2 receptors in cells
of hematopoetic origin is not yet known. The stim-
ulation of proliferation, secretion of mediators,
apoptosis or necrosis have been reported depending
on cell type as well as on the duration and concen-
tration of ATP application [2^4].
P2Z receptors in human B lymphocytes display the
same pharmacological pro¢le as in macrophages, ¢-
broblasts and mast cells, but the ATP-induced pores
allow permeation only for molecules 6 400 Da [5].
Electrophysiological studies demonstrated the gating
by ATP43 of a current which could be carried by
small inorganic cations. The ATP43 concentration
for half maximal activation of the non-desensitizing
currents was 200 WM. The activation and deactiva-
tion of this current were complete within less than
100 ms [6]. Single channel studies in Epstein-Barr
virus transformed and tonsillar human B cells re-
vealed ionic channels with a single channel conduc-
tance of 9 pS which also did not desensitize. The
channels were opened by ATP and BzATP in a con-
centration range typical of P2Z. Therefore, these
channels were assumed to carry at least one part of
the current measured in the whole-cell con¢guration
[7].
Recently, a subtype of the P2X receptor family,
named P2X7, was cloned with typical characteristics
of pore-forming P2Z receptors [8,9]. After the short
administration of ATP to mammalian cells express-
ing P2X7, these receptors were reported to open ionic
channels permeable to small cations only. However,
extended applications of ATP or BzATP to P2X7
receptors in solutions with low divalent cation
concentration induced pores for large molecules
like the propidium dye YO-PRO-1 (629 Da). For
the rat phenotype, these pores closed very slowly
(only after a few minutes) after the removal of the
agonist [9].
Xenopus oocytes were used as an expression system
for the electrophysiological characterization of the
hP2X7 receptor subtype found in human B lympho-
cytes. The aim of this study was to examine whether
the previously characterized native P2Z of human B
lymphocytes [6,7] exhibits exactly the same pheno-
type as the cloned P2X7. To this end, we isolated
the cDNA of the P2X7 from human B lymphocytes
and overexpressed the encoded receptor in Xenopus
oocytes for electrophysiological characterization.
2. Methods
2.1. Chemicals
Chemicals were obtained from Sigma (Deisenho-
fen, Germany) if not otherwise stated.
2.2. Isolation of human P2X7 cDNA from human B
lymphocytes by RT-PCR
cDNA comprising the entire coding region of
P2X7 was ampli¢ed by reverse transcription-poly-
merase chain reaction (RT-PCR) from the total
RNA of human B lymphocyte RNA using gene-
speci¢c primers (capitals) £anked by an XbaI-site
(forward: 5P-aatctagaGCAGGGAGGGAGGCTGT-
CACCAT; reverse: 5P-aatctagaGCCTGGCTTCAG-
TAAGGACTCTTGAA). PCR primers were de-
signed from the published human P2X7 sequence
([8], accession number Y09561). PCR products were
size-selected by agarose gel electrophoresis and
cloned into an XbaI site of vector pNKS2 [10]. The
insert was fully sequenced on both strands using the
dideoxynucleotide method. The amino acid sequence
deduced deviated in two positions (G441 and A496)
from the published sequence [8].
2.3. cRNA synthesis
Capped cRNAs were synthesized from linearized
templates with SP6 RNA polymerase (Pharmacia),
puri¢ed by Sepharose chromatography and phenol^
chloroform extraction [11] and dissolved in 5 mM
Tris/HCl, pH 7.2, at 0.5 Wg/Wl, using the optical den-
sity reading at 260 nm for quantitative analysis
(OD1:0 = 40 Wg/Wl).
2.4. Oocyte treatment
Xenopus laevis females were imported from the
African Xenopus Facility (Knysna, Republic of
South Africa). The animals were anaesthetized in
an aqueous solution supplemented with tricaine
(MS222, solution a, see Table 1). Parts of the ovary
were removed through a small incision and treated
overnight with collagenase (solution b) for defollicu-
lation. After several washes in nominally Ca2-free
salt solution (solution c), the oocytes were placed in
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Petri dishes containing normal salt solution (solution
d). Stage V or VI oocytes were injected with 20^50 nl
of cRNA and then kept in normal salt solution sup-
plemented with antibiotics (solution e) at 19‡C until
used 2^4 days later.
2.5. Electrophysiology
All experiments were carried out at room temper-
ature (W22‡C). Fast and reproducible solution ex-
change was achieved using a small tube-like chamber
(0.1 ml) combined with fast superfusion (W75 Wl/s).
Switching between di¡erent bathing solutions was
performed by a set of computer-controlled magnetic
valves using a modi¢ed U-tube technique [12].
The measurement of membrane currents was per-
formed by the two-microelectrode voltage clamp
method. Microelectrodes were pulled from borosili-
cate glass and ¢lled with 3 M KCl. Only electrodes
with resistances of between 0.5 and 1 M6 were used.
Currents were recorded and ¢ltered at 100 Hz using
an oocyte clamp ampli¢er (OC-725C, Hamden,
USA) and sampled at 85 Hz. Data were stored and
analyzed on a personal computer using software pro-
grammed at our department (Superpatch 2000, SP-
Analyzer by T. Bo«hm).
The holding potential was set to 340 mV, if not
otherwise stated. For the characterization of the
permeation behavior, the oocyte cell membrane was
depolarized by voltage ramps going from 380 to
+40 mV within 300 ms. The reversal potentials of
the resulting ramp-like currents were determined
by a linear ¢t of the current near the reversal poten-
tial which additionally yielded the slope conduc-
tance.
In oocytes injected with H2O, 1 mM extracellular
ATP induced no or very small inward currents (6 1
nA). In some cases, larger currents (6 4 nA) were
evoked, but only by the ¢rst application of ATP.
Concentrations of agonists always refer to the free
form not complexed by Ca2, Mg2 or Ba2. That
means, for bathing solutions containing 1 mM Ba2
the absolute amounts of ATP had to be calculated to
adjust the correct concentrations of the free nucleo-
tide (ATP43). This was done by a computer program
kindly provided by R. Schubert [13].
Non-linear approximations and presentation of
data were performed using the program Sigmaplot
(Jandel, Corte Madeira, USA). Averaged data are
given as means þ S.D. if not otherwise stated. Statis-
tical data were analyzed by one-way ANOVA. The
statistical signi¢cance of di¡erences between means
was tested using the multiple t-test (Bonferroni) by
the program Sigmastat (Jandel).
3. Results
3.1. Speed of solution exchange
The oocytes were held for 1^3 min at +40 mV to
induce a Na-selective conductance [14]. Afterwards,
the bathing solution was changed from a normal
oocyte Ringer (solution A, see Table 2) to a low
Na high K bathing solution (solution H, wash-
in), thereby inducing a shift of the holding current,
the time course of which re£ected the time course of
Table 1
Preparation solutions. Concentrations are in mM if not otherwise stated
a b c d e
NaCl 100 100 100 100
KCl 1 1 1 1
MgCl2 1 1 1 1
CaCl2 1 1 1
HEPES 5 5 5 5 5
Penicillin (U/ml) 10 000
Streptomycin (mg/ml) 10
Collagenase (mg/ml) 1.5
Tricaine (g/l) 2
pH was adjusted to 7.4 with NaOH for Na-containing solutions or with choline-Cl for choline-containing solutions, respectively.
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wash-in. After 6 s, this solution was washed out by
solution A. A typical example of the time course of
shifting the holding current as a result of this solu-
tion exchange is shown in Fig. 1. The mean 10^90%
exchange times were 1210 þ 70 ms for the wash-in
and 1770 þ 170 ms for the wash-out.
3.2. Complex kinetics of hP2X7-receptor currents in
extracellular solutions containing Ba2+
The impalement of the electrodes and measure-
ment of the membrane potential of the oocytes was
carried out in normal oocyte Ringer (solution A). To
avoid the activation of endogenous currents acti-
vated by Ca2 ions permeating the hP2X7 receptor
channels, the subsequent measurements of hP2X7 re-
ceptor-dependent currents were carried out in bath-
ing solutions with Ca2 equimolar replaced by Ba2.
This was reported to block Ca2-induced Cl3 cur-
rents [15]. Furthermore, Mg2 ions were omitted to
prevent complexation of ATP43 by Mg2. The nat-
ural agonist of lymphocytic P2Z receptors is ATP43
[1,7]. Free [ATP43] saturating the receptor could not
be achieved in the presence of Mg2, Ca2 or Ba2
because of the complexation of ATP and the corre-
sponding divalent ions. ATP and divalents are in-
soluble in the necessary high total concentrations.
During long term ATP applications in Ba2-con-
taining solutions (solution C) complex kinetics of
activation and deactivation were observed (Fig.
2A). Within the ¢rst 20^30 s the hP2X7 displayed a
fast exponential activation followed by a slow ap-
proximately linear current enlargement. Thereafter,
the holding current as well as the conductance in-
creased much faster, leading to very large currents.
At the same time, the inward recti¢cation of the
ramp current changed to a slight outward recti¢ca-
tion (Fig. 2B,C). The deactivation phase consisted
mainly of two components: a ¢rst fast deactivation
was followed by a very slow deactivation lasting
more than 70 s. During the deactivation the outward
recti¢cation of the ramp currents became more
prominent (Fig. 2D,E).
The observed slow deactivation seems to be similar
to the deactivation kinetics of P2X7 expressed in
mammalian cells [8,9], in which a prolonged ATP
application induces non-selective pores. On the other
hand, the slow deactivating current component ob-
served here could also be induced by the sustained
in£ux of Ba2 through the hP2X7 channels. To dis-
Fig. 1. Time course of solution exchange within the oocyte per-
fusion chamber. The oocyte was clamped at a holding potential
of +40 mV. The bathing solution was changed by means of a
set of computer-controlled magnetic valves from a high Na
low K standard oocyte Ringer solution (‘Na’, solution A, see
Table 1) to a low Na high K solution (‘K’, solution H) and
back to the standard oocyte Ringer solution as indicated on the
top of the ¢gure.
Table 2
Bathing solutions
A B C D E F G H
NaCl 100 100 100 100 100 2.5
KCl 2.5 2.5 2.5 2.5 2.5 2.5 2.5 100
MgCl2 1 1
CaCl2 1 1
BaCl2 1 1 1
HEPES 5 5 5 5 5 5 5 5
Flufenamic acid 0.1 0.1 0.1 0.1 0.1
EGTA 0.1
CholineCl 100 100
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criminate between these two possibilities the follow-
ing experiments were carried out in extracellular so-
lutions free from divalent cations. Under these cir-
cumstances any divalent-induced currents could be
eliminated. Furthermore, the absence of divalent cat-
ions is reported to promote the induction of pores
and a non-selective slowly deactivating conductance
by P2X7 in mammalian cells [8,9] That means, if
pores are responsible for the slow deactivating com-
ponent shown in Fig. 2A, it should be augmented
under these experimental conditions.
3.3. Kinetics of hP2X7-receptor currents in divalent
free extracellular solutions
The removal of divalent cations from the extracel-
lular solution evoked a large conductance. It could
be blocked by 0.1 mM £ufenamic acid [16,17]. The
e¡ect of £ufenamic acid on hP2X7-dependent cur-
rents was measured in extracellular solution contain-
ing 1 mM Ba2 to suppress the large conductance
developing in the absence of £ufenamic acid and di-
valent cations (Fig. 8A). Under these conditions,
Fig. 2. E¡ect of long term applications of ATP to human P2X7-receptors in Ba2-containing bathing solution. The concentration of
free ATP (ATP43) was 0.1 mM. (A) Typical time course of P2X7-receptor current. Bathing solution contained 1 mM Ba2 as divalent
cation (solution C, Table 2). (B^E) ATP-induced ramp currents (solid lines) as indicated in (A) but after subtraction of the mean
ramp current before ATP application with linear ¢t of the current slope at the reversal potential (dashed lines). The ¢tted reversal po-
tentials are +1 mV (B), 37 mV (C), 320 mV (D) and 321 mV (E).
Table 3
Kinetics of hP2X7 expressed in oocytes activated by 1 mM ATP in solution D (n = 25) or by 0.1 mM ATP43 in solution B and C
(n = 6)
Parameter 1 ATP, 0 Ba, 0.1 £uf. 0.1 ATP, 1 Ba, 0 £uf. 0.1 ATP, 1 Ba, 0.1 £uf. 0.1 ATP, 1 Ba, 0.1 £uf./0 £uf.
dact (s) 0.9 þ 0.3 0.25 þ 0.1 0.37 þ 0.1 1.50 þ 0.32*
Iact (nA) 3244 þ 139 3101 þ 64 392 þ 55 0.94 þ 0.08
c (nA/s) 319 þ 8 313 þ 7 316 þ 8 1.25 þ 0.07*
Ideact;2/Ideact;1 0.20 þ 0.10 0.13 þ 0.07 0.10 þ 0.07 0.68 þ 0.32*
ddeact;1 (s) 0.9 þ 0.3 3.5 þ 0.6 3.3 þ 0.6 0.95 þ 0.08
ddeact;2 (s) 6.2 þ 2.0 14.8 þ 2.8 16.2 þ 4.8 1.20 þ 0.33
Abbreviations, see explanation of Eqs. 1 and 2. Means þ S.D., *P6 0.05.
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only ATP43-concentrations up to 0.3 mM could be
tested. At higher concentrations, ATP was not fully
soluble. Flufenamic acid increased hP2X7-dependent
currents by about 16% at ATP43-concentrations of
v0.1 mM (Fig. 8A) mainly due to an increase of the
slope of the linearly rising component c (Table 3).
The addition of £ufenamic acid to the bath (change
from solution B to C) never evoked inward currents
s 2 nA. Further e¡ects of £ufenamic acid are a de-
celeration of the activation and a decrease of the
ratio of the two components of deactivation,
Ideact;2/Ideact;1. A detailed pharmacological pro¢le of
the di¡erent components of the hP2X7-dependent
currents according to Eqs. 1 and 2 including the
e¡ects of £ufenamic acid is currently under investi-
gation. Nevertheless, the principal characteristics of
hP2X7-dependent currents (two components of acti-
vation and of deactivation as well as the activating
concentration range for ATP43) seem not to be al-
tered by £ufenamic acid.
Fig. 3A demonstrates a current activated by ATP
in divalent free extracellular solution. The current at
340 mV displayed after an initial phase of approx-
imately exponential activation, a further current
component that increased linearly with time. The ac-
tivating part of the hP2X7-receptor current (IP2X7(t))
was ¢tted according to:
IP2X7;actt  Iact 13e
3
t
d act
0@ 1A cWt I0 1
where Iact is the activating current, I0 is the steady-
state current without ATP application, dact is the
time constant for activation and c is the slope of
the linearly rising current.
The best approximation of the deactivating current
(IP2X7;deact) during washout of ATP was achieved by
use of:
IP2X7;deactt 
Ideact Ideact;1We
3
t
d deact;1  Ideact;2We
3
t
d deact;2
0B@
1CA I0
2
Fig. 3. E¡ect of extended applications of ATP to human P2X7-receptors in divalent free bathing solution. (A) Typical time course of
P2X7-receptor current. Bathing solution without divalent cations (solution E, Table 2). The cell membrane was depolarized every 6 s
by voltage ramps (see text) leading to ramp-like current de£ections. Between these ramps the membrane was held at 340 mV. The
current at 340 mV showed an exponential activation with a time constant of 0.9 s (¢tted by Eq. 1) and a nearly linear slow current
increase lasting until ATP washout. The removal of ATP led to a rapid deactivation with 90% of the current deactivating with a time
constant ddeact;1 = 0.6 s. The remaining current deactivated with a time constant ddeact;2 = 4.6 s (¢tted by Eq. 2). (B^D) ATP-induced
ramp currents (solid lines) as indicated in (A). The ¢tted reversal potentials are +1 mV (A), 31 mV (B) and 36 mV (C). Same cell as
in Fig. 2. For further explanations see Fig. 2.
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where I0 has the same meaning as in Eq. 1 and Ideact
is the absolute amplitude of the deactivating current.
Ideact;1 and Ideact;2 are the relative amplitudes, and
ddeact;1 and ddeact;2 are the time constants of the fast
and slow deactivating component, respectively.
The activation and deactivation kinetics were not
signi¢cantly altered by shortening the duration of
ATP application to 6 s. The statistics of the kinetics
of hP2X7 are given in Table 3. The mean value of the
slope of the linearly rising component c was signi¢-
cantly di¡erent from 0.
3.4. Permeation behavior during long term ATP
applications
In Na-containing divalent free bathing solution,
the reversal potential Vrev did not shift during 30 s of
exposure to 0.1 mM ATP43 (31.8 þ 1.9 mV, not sig-
ni¢cantly di¡erent from 0). If Ba2 was added to this
solution, Vrev shifted signi¢cantly by 311.7 þ 5.0 mV.
In divalent free extracellular solutions with Na
substituted by choline (Fig. 4) the current kinetics
were similar to currents measured in divalent free
oocyte Ringer. A fast exponential activation was
followed by a linear rise of the holding current
and conductance and the deactivation was complete
within a few seconds (Fig. 4A). The very negative
reversal potential was only slightly shifted to more
positive values (Fig. 4B^D). On average the reversal
potential was slightly but signi¢cantly shifted during
30 s of application of 0.1 mM ATP43 by +2.9 þ 1.7
mV.
After long term ATP applications (s 20 s) in Na-
free solutions containing Ba2 (solution F, data not
shown) the time of deactivation to the value of hold-
ing current before ATP43-application þ 20 nA lasted
more than 1 min. Additionally, during 30 s of
ATP43-application the inward recti¢cation changed
to an outward recti¢cation and the reversal potential
was signi¢cantly shifted by +11.7 þ 2.6 mV.
3.5. Permeation behavior during short term ATP
applications
The permeation was characterized by measuring
the reversal potentials of the hP2X7 receptor-de-
pendent current in di¡erent extracellular solutions
(Fig. 5).
To characterize the permeation of hP2X7 by Ba2
the reversal potential in Ba2-containing solutions
was measured after short term ATP applications
(6 6 s). Under these circumstances the deactivation
was not signi¢cantly di¡erent from the deactivation
behavior in Ba2-free external solutions. This indi-
Fig. 4. E¡ect of long lasting applications of ATP to human P2X7-receptors in Na-free bathing solution. (A) Typical time course of
P2X7-receptor current. Bathing solution contained choline instead of Na (solution G, Table 2). (B^D) ATP-induced ramp currents
(solid lines) as indicated in (A). For further explanations see Fig. 3.
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cated the absence of additional Ba2-induced current
components.
The reversal potential in Na-containing Ringer
solutions was about 0 mV independent of the
Ba2-concentration. In bathing solution with Na
replaced by choline the reversal potential was very
negative indicating a high selectivity for Na over
the larger choline. The reversal potential in Na-
free solutions was signi¢cantly shifted to more pos-
itive values by the addition of 1 mM Ba2 to the
bathing solution. This points to a substantial Ba2
permeability of hP2X7.
3.6. Reproducibility of activation of hP2X7
As shown in Fig. 6A, the currents induced by ATP
in divalent free bathing solution were highly repro-
ducible even if ATP was applied several times in
short intervals. The currents always returned within
several seconds to the holding current before the ¢rst
ATP application. The deactivation time course after
each stimulation by ATP was obviously nearly iden-
tical. If the typical agonist of P2Z and P2X7-recep-
tors, BzATP, was used to activate the hP2X7 recep-
tors a potentiating e¡ect on the current amplitude
was observed which was pronounced in the ¢rst 2
min after the ¢rst BzATP application (Fig. 6B).
The deactivation time course, on the other hand,
was obviously not altered by repeated addition of
either agonist to the bath.
3.7. ATP concentration^response relationship
For determination of the dependence of the ampli-
tude of hP2X7 receptor currents on the agonist con-
centration, di¡erent concentrations of ATP or
BzATP, were applied in divalent free extracellular
solution. The hP2X7 receptor-dependent current IP
was measured as the current after 5 s of agonist
application minus the current before agonist applica-
tion. To account for the various extent of receptor
expression the hP2X7 receptor-dependent current
evoked by a certain concentration of the agonists
IP([agonist]) was normalized to the control hP2X7
Fig. 6. Reproducibility of P2X7-receptor currents gated by
P2X7-agonists. Solution E was used as extracellular solution.
Typical examples of the e¡ect of repeated application of ATP
(A) or BzATP (B) on two di¡erent oocytes expressing hP2X7.
The duration of agonist application is marked by horizontal
bars. The 90^10% deactivation times for the fraction of the cur-
rent traces marked by an asterisk are 5.8, 6.1 and 5.9 s for
ATP- (A) and 4.0, 1.8 and 2.1 s for BzATP-induced currents
(B), respectively.
Fig. 5. Permeation behavior of human P2X7-receptors. The re-
versal potentials of ramp currents measured according to Fig.
3B^D were determined 5 to 20 s after addition of 1 mM ATP
in distinct extracellular solutions as indicated on the abscissa
and on the bottom of the ¢gure. Di¡erent symbols on the top
indicate statistically di¡erent means. Numbers within the bars
correspond to the number of investigated oocytes.
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receptor-dependent current IP;cont evoked by 1 mM
ATP. The dose^response curve for ATP was ¢tted by
the Hill equation with a Hill coe⁄cient of 1:
IP;rel  IPagonistIP;cont 
IP;rel;max
1 10
3logEC50
agonist
3
where IP;rel;max is the maximal relative hP2X7 recep-
tor current evoked by in¢nite concentrations of the
agonist and EC50 is the concentration of half max-
imal current activation.
Models with di¡erent Hill coe⁄cients did not de-
scribe the data signi¢cantly better [18]. The approx-
imations yielded a log EC50 value of 33.40 þ 0.06
(see Fig. 7).
Fig. 8. E¡ect of £ufenamic acid and HMA on hP2X7 receptor-dependent currents. The agonist concentrations applied for 6 s to evoke
hP2X7-dependent inward currents are given at the abscissas. (A) Concentration^response curves for ATP43 in bathing solutions con-
taining 1 mM free Ba2 and 0 or 0.1 mM £ufenamic acid, respectively (bathing solution B versus C). At ATP43-concentrations of 0.1
and 0.3 mM, £ufenamic acid induced a small but signi¢cant increase of the maximal hP2X7-dependent current IP (see Section 3.7 and
Eq. 3). (B^D) E¡ect of HMA on the exponentially (Iact;rel) and the slope of the linearly-activating current (crel) as well as on the rela-
tion of these both components ((Iact/c)rel). Bathing solution (D) was used supplemented with HMA as given in the legend to (D).
Data are normalized to the controls measured in bathing solutions without HMA. Mean values signi¢cantly di¡erent from the con-
trols are marked by asterisks.
Fig. 7. Concentration^response curves for hP2X7 receptor-de-
pendent currents. hP2X7 receptor-dependent currents evoked by
application of di¡erent concentrations of agonist for 6 s were
normalized to the current induced by at 1 mM ATP. Means
from 12 oocytes are shown. Bathing solution (E) was used. The
data for ATP-induced currents were ¢tted according to Eq. 3.
For further explanations, see text.
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3.8. E¡ect of hexamethylene amiloride (HMA) on
hP2X7-dependent currents
HMA is known as a blocker of large pores formed
after the activation of purinergic receptors of macro-
phages [19]. As shown in Fig. 8B^D, in oocytes ex-
pressing hP2X7, 100 WM HMA is not able to block
BzATP- or ATP-evoked currents completely. This is
in contrast to oocytes injected with macrophage
mRNA. Interestingly, HMA blocks both the expo-
nentially- as well as the linearly-activating current
component of ATP-evoked currents to about 40^
50% whereas it inhibits only the exponentially-acti-
vating component of currents elicited by the applica-
tion of BzATP. This ¢nding will be investigated fur-
ther in future experiments.
4. Discussion
4.1. Relevance of hP2X7 to the P2Z phenotype
The use of £ufenamic acid to block currents acti-
vated by removal of divalent cations from the bath-
ing solution [16,17] allowed the performance of ex-
periments in extracellular solutions which were
completely free from divalent cations. This simpli¢ed
the investigated system because the in£uence of other
ionic currents secondarily activated by an in£ux of
divalent cations was avoided. The hP2X7 receptor
behaves similar to the native P2Z receptor found in
human B lymphocytes with respect to the fast acti-
vation, ATP and BzATP concentration^response re-
lationship, reproducibility, permeation characteristics
and lack of desensitization of the ATP-evoked cur-
rents. However, two main di¡erences exist : ¢rstly,
the hP2X7-dependent current displays a slowly, line-
arly increasing current component during long ATP
applications not detected in B lymphocytes [6]. The
long term agonist addition to the bathing solution
did not obviously change either recti¢cation, reversal
potential or the deactivation time course. Therefore,
this additional current component seems not to be
carried by other ionic channels, secondarily opened
due to the gating of hP2X7 or a slow enlargement of
the hP2X7 receptors channel pore.
Secondly, an additional, small and slowly deacti-
vating current component exists only in hP2X7 ex-
pressed in oocytes and was neither found in whole-
cell [6] nor single channel measurements [7] of P2Z in
human B lymphocytes. The presence of divalent ions
in the experiments carried out in human B lympho-
cytes is probably not responsible for the di¡erent
behavior of the lymphocytic P2Z receptor, because
the linear-increasing component as well as the second
slow deactivating component of hP2X7-dependent
currents was also measured in oocytes using Ba2-
containing extracellular solutions (data not shown).
The measurements of current kinetics may be some-
what biased by the time course of the solution ex-
change. Nevertheless, the ¢nding that hP2X7 displays
slowly activating and deactivating components addi-
tional to the native lymphocytic P2Z receptor [6,7] is
not in question because the time course of these com-
ponents is obviously slower than the solution ex-
change.
4.2. Species-related comparison of the e¡ects of
agonists and the kinetics of P2X7 expressed in
di¡erent cell systems
Like in other described preparations, BzATP is the
more potent and e¡ective agonist at P2X7 receptors
in comparison to ATP. That means, similar to the
lymphocytic P2Z receptor [20], ATP is only a partial
agonist. However, the EC50 value of about 400 WM
found for ATP43 at hP2X7 in oocytes is much higher
than the 3 WM measured for the rat P2X7 in the same
expression system [21].
The concentration^response relationship for
ATP43 could be well ¢tted with a Hill coe⁄cient of
1 similar to P2Z-mediated whole-cell currents in hu-
man B lymphocytes and HMA-insensitive BzATP-
induced currents in oocytes injected with macro-
phage mRNA [19]. On the other hand, higher Hill
coe⁄cients were reported for the HMA-sensitive cur-
rent in macrophage RNA-injected oocytes [19] and
for P2Z-receptors mediated Ba2-in£ux in human
leukemic B lymphocytes [4,5]. Therefore, it could
be assumed that the currents measured here represent
the rapid, HMA-insensitive component of the
BzATP-inducible current carried by macrophage pu-
rinergic receptors and that the activation of this com-
ponent requires the binding of a single molecule of
BzATP or ATP to the receptor. Furthermore, it
could be concluded that the Ba2-in£ux in human
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leukemic B lymphocytes is not or not only carried by
this component. We feel, however, that this assump-
tion is highly speculative and that the number of
agonist binding sites cannot be determined solely
by concentration^response curves. Therefore, the ap-
proximation shown for the data of our experiments
should mainly characterize the concentration range
at which activation of hP2X7 takes place. The con-
centration of half maximal activation of about 400
WM ATP43 is not far from the 200 WM reported for
human B lymphocytes. The di¡erence may arise from
the absence of a clearly de¢ned plateau of the current
amplitude at high concentrations of ATP43 in lym-
phocytes. This is due to the fact that divalent cations
have to be added to the extracellular solution to
obtain stable tight seals for whole-cell voltage clamp
recordings in lymphocytes. This leads to insoluble
Ca-ATP complexes at high [ATP43] (see also Section
3.2).
The human P2X7 expressed in oocytes (this study)
conducted currents with nearly constant fast deacti-
vation if agonists were repeatedly applied in divalent-
free extracellular solution. This is in contrast to
hP2X7 expressed in HEK 293 cells [8,22] and to rat
P2X7 expressed in Xenopus oocytes [21] where pro-
gressively increasing deactivation time constants were
measured under these conditions. It is a further in-
dication of the disability of hP2X7 to induce non-
selective slowly deactivating pores in Xenopus oo-
cytes. Additionally, in the oocyte expression system,
the hP2X7-dependent currents were potentiated by
repeated application of BzATP, but the rat P2X7
displayed a strong reduction of the current amplitude
during consecutive BzATP applications [21]. Taken
together, these ¢ndings point to profound species
di¡erences for P2X7. Di¡erent expression systems
seem also to be responsible for di¡erent properties
of P2X7 even of the same species.
Another interpretation of the di¡erent kinetics
may be, that the deactivation measured in mamma-
lian expression systems does not only re£ect the clo-
sure of the hP2X7-receptor channel pore but, beyond
it, the deactivation of components which could have
been additionally activated by the P2X7-receptor. At
least for the rat P2X7, this putative component seems
to be related to the opening of the large pores. It is
still an unresolved issue if these pores arise from the
enlargement of the P2X7 ion conducting pathway
itself or re£ect the activation of other ion-conducting
pathways. Indications for the former [23^25] as well
as the latter [26^28] hypothesis have been published.
It is also imaginable that both mechanisms may also
act in parallel. It is tempting to speculate that these
additional pore molecules once activated via the
P2X7-receptor are deactivated slowly after wash out
of ATP causing a slow deactivation of the whole-cell
current. If these pore molecules were only expressed
in mammalian cells and not in Xenopus oocytes, the
deactivating whole-cell currents measured in the oo-
cyte expression system would re£ect the closure of
only the hP2X7-pore. This would account for the
faster deactivation of hP2X7-dependent currents in
oocyte system compared to mammalian cells. Single
channel measurements of hP2X7-dependent currents
should help to clarify this issue.
4.3. Permeation characteristics
As reported for rat P2X7 expressed in Xenopus
oocytes [21], the reversal potential of ATP-induced
currents of human P2X7 did not change during ex-
tended ATP applications. Furthermore, HMA in-
completely blocks both the exponentially and the lin-
early-activating component of ATP-evoked hP2X7-
dependent currents in oocytes to about the same ex-
tent. This is in contrast to oocytes injected with mac-
rophage mRNA in which the formation of large
pores is selectively inhibited. It argues against the
induction of large pores by P2X7 in oocytes which
have been observed in mammalian cells expressing
human, rat or mouse P2X2, P2X4 or P2X7 receptors
[8,9,23,24,29]. It has been reported [19] that at tem-
peratures higher than room temperature the forma-
tion of large pores is promoted in cells expressing the
P2Z phenotype. Unfortunately, it is not possible to
perform experiments in oocytes at temperatures high-
er than room temperature which is known to pro-
mote pore formation. In HEK293 cells expressing the
rat P2X7 receptor, at room temperature Virginio et
al. [25] observed a signi¢cant pore enlargement after
the application of 3 WM BzATP within 6 20 s.
Under their experimental conditions, 30 WM BzATP
induced membrane blebbing and membrane disrup-
tion within 30 s. We can certainly not exclude that
during very long (lasting several minutes) applica-
tions of ATP an enlargement of the hP2X7 channel
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pore also takes place in oocytes. But the application
of 1 mM ATP for 2 h to unclamped oocytes express-
ing hP2X7 never resulted in the cytolysis of the oo-
cytes. Similarly, the survival rate of oocytes injected
with P2X7 cRNA was not obviously shorter than
that of water-injected oocytes.
Therefore, like the rat P2X7 [21], the human P2X7
itself seems to be unable to generate large pores in
Xenopus oocytes at least under our experimental con-
ditions. It is possible that further components are
involved in the induction of non-selective pores in
mammalian cells.
However, if the extracellular solution contained
1 mM Ba2, we observed in oocytes extended deac-
tivation components which were also described in
mammalian cells expressing P2X7. Additionally, we
measured under these conditions a change from in-
ward to outward recti¢cation as well as a shift of the
reversal potential to values in the range of 328 to
312 mV which is close to the reported reversal po-
tential for Cl3-currents in Xenopus oocytes [30]. Be-
cause, like lymphocytic P2Z receptors [5,6], hP2X7
channels are highly permeable to Ca2 [31] and ob-
viously also to Ba2 (see Fig. 5) a Ba2-induced Cl3-
conductance may be responsible for the additional
current component. It is not clear if this conductance
corresponds to IClCa which could be transiently ac-
tivated by Ca2-entry through voltage-dependent
Ca2-channels. IClCa could not be evoked by depo-
larization of the oocytes if Ca2 was replaced by
Ba2 [15]. However, the depolarization-induced in-
ward current is transient whereas the activation of
hP2X7 in oocytes might maintain a Ba2-in£ux for
several seconds which could be su⁄cient to induce
IClCa.
The reversal potential of hP2X7-dependent cur-
rents was found at about 0 mV in this study. This
is in accordance with reports on P2X1ÿ4-subtypes
[31] and the results point to an approximately equal
permeability for Na and K. Contrary to these
¢ndings, a reversal potential of ^20 mV was found
for rat P2X7 expressed in oocytes [21]. This refers to
di¡erent permeation characteristics of rat and human
P2X7-receptors. Substitution of extracellular Na by
choline shifted the reversal potential by about 360
mV. This indicates that hP2X7 receptors are scarcely
permeable to this organic cation (molecular weight of
121 Da). This corresponds to other measurements on
heterologously expressed P2X1ÿ4-subtypes [31] and
to the shift of +53 mV observed in human B lym-
phocytes when intracellular Na was replaced by
Tris (MW also 121 Da) [6]. Therefore, the perme-
ation characteristics of P2Z in human B cells and
hP2X7 expressed in oocytes are similar to those of
other P2X subtypes but di¡er from hP2X7 heterolo-
gously expressed in mammalian cells and rat P2X7
expressed in oocytes.
4.4. Prospects
The hP2X7 receptor expressed in oocytes does not
match the lymphocytic P2Z completely. One reason
for these di¡erences may be the non-mammalian ex-
pression system for hP2X7 possibly di¡ering in addi-
tional components necessary for the function of the
lymphocytic P2Z receptor. Another reason could be
inferred from the fact that P2X receptors are prob-
ably composed of three submits [32]. It is therefore
conceivable that heteropolymerization of the hP2X7
receptor with hP2X1 and hP2X4 subunits addition-
ally found in human B lymphocytes (preliminary re-
sults) may produce ATP-gated currents that are dif-
ferent from currents carried by pure hP2X7 subunits.
Heteropolymerization of P2X subunits has already
been observed in neurons ([33], for example). Further
experiments like coexpression of di¡erent hP2X sub-
units together with single channel measurements are
necessary for the detailed characterization of the
structure and subunit assembly of the human lym-
phocytic P2Z receptor. The characterization of the
investigated single hP2X7 subtype may help in future
experiments to reveal possible new characteristics of
such putative ATP-gated channels.
Acknowledgements
This work was supported by the Deutsche For-
schungsgemeinschaft (Ma 1581/2-2).
References
[1] F. Di Virgilio, Immunol. Today 16 (1995) 524^528.
[2] F. Di Virgilio, P. Chiozzi, S. Falzoni, D. Ferrari, J.M. Sanz,
V. Venketaraman, O.R. Baricordi, Cell Death Di¡er. 5
(1998) 191^199.
BBAMEM 77906 9-8-00
M. Klapperstu«ck et al. / Biochimica et Biophysica Acta 1467 (2000) 444^456 455
[3] C. El-Moatassim, J. Dornand, J.C. Mani, Biochim. Biophys.
Acta 1134 (1992) 31^45.
[4] J.S. Wiley, J.R. Chen, M.B. Snook, G.P. Jamieson, Br. J.
Pharmacol. 112 (1994) 946^950.
[5] J.S. Wiley, R. Chen, G.P. Jamieson, Arch. Biochem. Bio-
phys. 305 (1993) 54^60.
[6] F. Bretschneider, M. Klapperstu«ck, M. Lo«hn, F. Mark-
wardt, P£uegers Arch. 429 (1995) 691^698.
[7] F. Markwardt, M. Lo«hn, T. Bo«hm, M. Klapperstu«ck,
J. Physiol. Lond. 498 (1997) 143^151.
[8] F. Rassendren, G.N. Buell, C. Virginio, G. Collo, R.A.
North, A. Surprenant, J. Biol. Chem. 272 (1997) 5482^5486.
[9] A. Surprenant, F. Rassendren, E. Kawashima, R.A. North,
G. Buell, Science 272 (1996) 735^738.
[10] S. Gloor, O. Pongs, G. Schmalzing, Gene 160 (1995) 213^
217.
[11] J.K. Yisraeli, D.A. Melton, Methods Enzymol. 180 (1989)
42^50.
[12] F. Bretschneider, F. Markwardt, Methods Enzymol. 294
(1999) 180^189.
[13] R. Schubert, Comp. Methods Progr. Biomed. 33 (1990) 93^
94.
[14] J. Rettinger, P£uegers Arch. 437 (1999) 917^924.
[15] M.E. Barish, J. Physiol. Lond. 342 (1983) 309^325.
[16] W.M. Weber, K.M. Liebold, F.W. Reifarth, U. Uhr, W.
Clauss, P£uegers Arch. 429 (1995) 820^824.
[17] Y. Zhang, D.W. McBride Jr., O.P. Hamill, J. Physiol. Lond.
508 (1998) 763^776.
[18] R. Horn, Biophys. J. 51 (1987) 255^263.
[19] L.C. Nuttle, G.R. Dubyak, J. Biol. Chem. 269 (1994) 13988^
13996.
[20] C.E. Gargett, J.E. Cornish, J.S. Wiley, Br. J. Pharmacol. 122
(1997) 911^917.
[21] S. Petrou, M. Ugur, R.M. Drummond, J.J. Singer, J.V.
Walsh, FEBS Lett. 411 (1997) 339^345.
[22] I.P. Chessell, A.D. Michel, P.P.A. Humphrey, Br. J. Phar-
macol. 124 (1998) 1314^1320.
[23] B.S. Khakh, X.R. Bao, C. Labarca, H.A. Lester, Nature
Neurosci. 2 (1999) 322^350.
[24] C. Virginio, A. MacKenzie, F.A. Rassendren, R.A. North,
A. Surprenant, Nature Neurosci. 2 (1999) 315^321.
[25] C. Virginio, A. MacKenzie, R.A. North, A. Surprenant,
J. Physiol. Lond. 519 (1999) 335^346.
[26] R. Coutinho-Silva, P.M. Persechini, Am. J. Physiol. 273
(1997) C1793^C1800.
[27] W.P. Schilling, W.G. Sinkins, M. Estacion, Am. J. Physiol.
277 (1999) C755^C765.
[28] W.P. Schilling, T. Wasylyna, G.R. Dubyak, B.D. Hum-
phreys, W.G. Sinkins, Am. J. Physiol. 277 (1999) C766^
C776.
[29] I.P. Chessell, J. Simon, A.D. Hibell, A.D. Michel, E.A. Bar-
nard, P.P.A. Humphrey, FEBS Lett. 439 (1998) 26^30.
[30] K. Kusano, R. Miledi, J. Stinnakre, J. Physiol. Lond. 328
(1982) 143^170.
[31] G. Buell, G. Collo, F. Rassendren, Eur. J. Neurosci. 8 (1996)
2221^2228.
[32] A. Nicke, H.G. Ba«umert, J. Rettinger, A. Eichele, G. Lam-
brecht, E. Mutschler, G. Schmalzing, EMBO J. 17 (1998)
3016^3028.
[33] C. Lewis, S. Neidhart, C. Holy, R.A. North, G. Buell, A.
Surprenant, Nature 377 (1995) 432^435.
BBAMEM 77906 9-8-00
M. Klapperstu«ck et al. / Biochimica et Biophysica Acta 1467 (2000) 444^456456
